Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease
Faecal microbiota transplantation (FMT) is currently a recommended therapy for recurrent/refractory Clostridioides difficile infection (CDI). The success of FMT for CDI has led to interest in its therapeutic potential in many other disorders. The mechanisms that underpin the efficacy of FMT are not...
Main Authors: | Jonathan P. Segal, Benjamin H. Mullish, Mohammed N. Quraishi, Tariq Iqbal, Julian R. Marchesi, Harry Sokol |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-09-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756284820946904 |
Similar Items
-
Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease
by: Mehmet Yalchin, et al.
Published: (2019-11-01) -
The future of faecal microbiota transplantation in gastrointestinal illness
by: Jakob Begun, et al.
Published: (2020-01-01) -
Gastrointestinal microbiome, what is behind faecal microbiota transplantation?
by: P. Thomson, et al.
Published: (2021-07-01) -
The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease
by: Jonathan P. Segal, et al.
Published: (2019-01-01) -
Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine
by: Nicolas Benech, et al.
Published: (2020-06-01)